| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |